Community-Based VCT Tanzania
坦桑尼亚社区 VCT
基本信息
- 批准号:7422440
- 负责人:
- 金额:$ 152.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-25 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAfricanAgeAll SitesAvidityAwarenessBedsBehavioralBiological AssayBlood specimenBudgetsCD4 Positive T LymphocytesCancer CenterCell CountClinicCollaborationsCommunicationCommunitiesCounselingCountryCzech RepublicDataDisciplineDisclosureEnd PointEnd Point AssayEnsureEthnographyEventFrequenciesFundingGoalsHIVHIV InfectionsHIV prevention trials networkHIV-1HealthHigh Pressure Liquid ChromatographyHouseholdHuman immunodeficiency virus testIncidenceInstitutionInternationalInterventionInterviewLaboratoriesLearningLifeLow PrevalenceMapsMeasuresMediationMethodologyMethodsModelingMonitorNational Institute of Mental HealthOutcomePersonsPhasePhase III Clinical TrialsPopulationPreparationPrevalencePrevention interventionProceduresProcessProtocols documentationPublic HealthQualifyingRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRateReadinessRelative (related person)ReportingResearch Ethics CommitteesResearch PersonnelResourcesRiskSamplingScheduleScienceScientistSecureServicesSiteSouth AfricaStandards of Weights and MeasuresStigmataSurveysSweatSweatingSystemTanzaniaTestingThailandTimeTimeLineTrainingTreatment EfficacyUniversitiesWorkZimbabweauthoritybasebehavior measurementcohortcommunity interventioncostcost effectivenessdata managementdesigndisability-adjusted life yearsexperiencefallshigh risk behaviorindexingmembermultidisciplinaryoutreachsocialsocial stigmatransmission processuptake
项目摘要
DESCRIPTION (provided by applicant): This is a Phase III, community-level, randomized controlled study, in which 48 communities (10 in Tanzania, 8 in Zimbabwe, 8 in South Africa-Soweto, 8 in South Africa-Vulindlela, and 14 in Thailand) were randomized to receive either a community-based HIV voluntary counseling and testing (CBVCT) intervention or standard clinic-based VCT (SVCT). The CBVCT intervention has three major strategies: (1) to make VCT more available in community settings; (2) to engage the community through outreach; and (3) to provide post-test support. These three strategies are designed to change community norms and reduce risk for HIV infection among all community members, irrespective of whether they participated directly in the intervention. The primary objective (Aim 1) of this study is to test the hypothesis that communities receiving 2-1/2 years of CBVCT, relative to communities receiving 2-1/2 years of SVCT, will have significantly lower prevalence of recent HIV infection. The secondary objective (Aim 2) is to test the hypotheses that CBVCT communities, relative to SVCT communities, will at the end of the intervention period report significantly: less HIV risk behavior, higher rates of HIV testing, more favorable social norms regarding HIV testing, more frequent discussions about HIV, more frequent disclosure of HIV status, less HIV-related stigma, and fewer HIV- related negative life events. Aim 3 of the study will be to assess whether CBVCT is cost-effective compared to SVCT. A random sample of persons aged 16 to 32 from each study community was selected at baseline, and will be selected post intervention, for measuring primary and secondary endpoints. Aim 1 will be evaluated by comparing the post-intervention prevalence of recent HIV infection in CBVCT and SVCT communities, using an algorithmic approach comprised of CD4+ T-cell counts, the HIV-1 BED Incidence EIA (Calypte), Avidity Index (BioRad), and HPLC for ART residues (HPTN Core Lab/JHU). Aim 2 will be evaluated by comparing a variety of behavioral measures at baseline and post intervention. Aim 3 will be evaluated in terms of cost per HIV infection averted and disability-adjusted life years (DALYs) saved.
描述(由申请人提供):这是一项 III 期、社区层面的随机对照研究,其中 48 个社区(坦桑尼亚 10 个、津巴布韦 8 个、南非索韦托 8 个、南非 Vulindlela 8 个、14 个)泰国)被随机分配接受基于社区的艾滋病毒自愿咨询和检测(CBVCT)干预或标准的基于临床的 VCT(SVCT)。 CBVCT 干预有三大策略:(1) 使 VCT 在社区环境中更容易获得; (2) 通过外展活动吸引社区参与; (3) 提供测试后支持。这三项策略旨在改变社区规范并降低所有社区成员感染艾滋病毒的风险,无论他们是否直接参与干预。本研究的主要目标(目标 1)是检验以下假设:相对于接受 2-1/2 年 SVCT 的社区,接受 2-1/2 年 CBVCT 的社区近期 HIV 感染率将显着降低。第二个目标(目标 2)是检验以下假设:相对于 SVCT 社区,CBVCT 社区在干预期结束时将显着报告:HIV 危险行为更少、HIV 检测率更高、有关 HIV 检测的社会规范更有利,更频繁地讨论艾滋病毒,更频繁地披露艾滋病毒状况,减少与艾滋病毒相关的耻辱,以及减少与艾滋病毒相关的负面生活事件。该研究的目标 3 将是评估 CBVCT 与 SVCT 相比是否具有成本效益。在基线时从每个研究社区随机抽取 16 至 32 岁的人样本,并将在干预后进行选择,用于测量主要和次要终点。将使用由 CD4+ T 细胞计数、HIV-1 BED 发生率 EIA (Calypte)、Avidity Index (BioRad) 组成的算法方法,通过比较 CBVCT 和 SVCT 社区中近期 HIV 感染的干预后患病率来评估目标 1和 ART 残留物的 HPLC(HPTN 核心实验室/JHU)。将通过比较基线和干预后的各种行为测量来评估目标 2。目标 3 将根据避免每次 HIV 感染的成本和节省的伤残调整生命年 (DALY) 进行评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael D Sweat其他文献
Michael D Sweat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael D Sweat', 18)}}的其他基金
The Evidence Project: Systematic Reviews of Critical HIV Interventions, and Disruption in HIV Services from COVID-19 in LMIC
证据项目:中低收入国家关键艾滋病毒干预措施的系统审查以及 COVID-19 对艾滋病毒服务造成的干扰
- 批准号:
10275167 - 财政年份:2021
- 资助金额:
$ 152.02万 - 项目类别:
The Evidence Project: Systematic Reviews of Critical HIV Interventions, and Disruption in HIV Services from COVID-19 in LMIC
证据项目:中低收入国家关键艾滋病毒干预措施的系统审查以及 COVID-19 对艾滋病毒服务造成的干扰
- 批准号:
10395612 - 财政年份:2021
- 资助金额:
$ 152.02万 - 项目类别:
The Evidence Project: Systematic Reviews of Critical HIV Interventions, and Disruption in HIV Services from COVID-19 in LMIC
证据项目:中低收入国家关键艾滋病毒干预措施的系统审查以及 COVID-19 对艾滋病毒服务造成的干扰
- 批准号:
10570851 - 财政年份:2021
- 资助金额:
$ 152.02万 - 项目类别:
Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care: an RCT in Kisarawe, Tanzania
艾滋病毒/非传染性疾病综合筛查对艾滋病毒检测的采用和参与艾滋病毒护理的影响:坦桑尼亚基萨拉韦的随机对照试验
- 批准号:
9750110 - 财政年份:2016
- 资助金额:
$ 152.02万 - 项目类别:
Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care: an RCT in Kisarawe, Tanzania
艾滋病毒/非传染性疾病综合筛查对艾滋病毒检测的采用和参与艾滋病毒护理的影响:坦桑尼亚基萨拉韦的随机对照试验
- 批准号:
9353480 - 财政年份:2016
- 资助金额:
$ 152.02万 - 项目类别:
Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care: An RCT in Kisarawe, Tanzaniz
艾滋病毒/非传染性疾病综合筛查对艾滋病毒检测的采用和参与艾滋病毒护理的影响:坦桑尼兹基萨拉韦的随机对照试验
- 批准号:
10449427 - 财政年份:2016
- 资助金额:
$ 152.02万 - 项目类别:
Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care: an RCT in Kisarawe, Tanzania
艾滋病毒/非传染性疾病综合筛查对艾滋病毒检测的采用和参与艾滋病毒护理的影响:坦桑尼亚基萨拉韦的随机对照试验
- 批准号:
9203236 - 财政年份:2016
- 资助金额:
$ 152.02万 - 项目类别:
Dyadic-Based Diagnosis, Care, & Prevention for HIV Discordant Couples in Tanzania
基于二元的诊断、护理、
- 批准号:
9119641 - 财政年份:2015
- 资助金额:
$ 152.02万 - 项目类别:
Dyadic-Based Diagnosis, Care, & Prevention for HIV Discordant Couples in Tanzania
基于二元的诊断、护理、
- 批准号:
9277597 - 财政年份:2015
- 资助金额:
$ 152.02万 - 项目类别:
Dyadic-Based Diagnosis, Care, & Prevention for HIV Discordant Couples in Tanzania
基于二元的诊断、护理、
- 批准号:
8846365 - 财政年份:2015
- 资助金额:
$ 152.02万 - 项目类别:
相似海外基金
Intersectional discrimination and linkage to HIV prevention and care in transgender women in Ecuador
厄瓜多尔跨性别妇女的交叉歧视及其与艾滋病毒预防和护理的联系
- 批准号:
10762136 - 财政年份:2023
- 资助金额:
$ 152.02万 - 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
- 批准号:
10754981 - 财政年份:2023
- 资助金额:
$ 152.02万 - 项目类别:
Adaptation and feasibility of Many Men Many Voices (3MV), an HIV prevention intervention to reduce intersectional stigma and increase HIVST among YSMM residing in Ghanaian slums
多男多声 (3MV) 的适应和可行性,这是一种艾滋病毒预防干预措施,旨在减少居住在加纳贫民窟的 YSMM 中的交叉耻辱并增加艾滋病毒传播与传播
- 批准号:
10756009 - 财政年份:2023
- 资助金额:
$ 152.02万 - 项目类别:
The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk.
COVID-19 时代艾滋病毒的面貌不断变化:通过动态定位当前和未来的感染风险分布,最大限度地降低艾滋病毒发病率。
- 批准号:
10548290 - 财政年份:2023
- 资助金额:
$ 152.02万 - 项目类别:
Designing an Ethnodrama Intervention Addressing PrEP Stigma Toward Young Women
设计民族戏剧干预措施,解决针对年轻女性的 PrEP 耻辱
- 批准号:
10755777 - 财政年份:2023
- 资助金额:
$ 152.02万 - 项目类别: